Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications
Author Information
Author(s): Bida Meshack, Miya Thabiso Victor, Hull Rodney, Dlamini Zodwa
Primary Institution: University of Pretoria, Hatfield, South Africa
Hypothesis
The review explores the prognostic value of tumor-infiltrating lymphocytes (TILs) in melanoma and their potential clinical applications.
Conclusion
TILs are promising biomarkers for predicting patient outcomes and improving treatment strategies in melanoma.
Supporting Evidence
- TILs have been shown to improve patient prognosis in melanoma.
- Immunotherapy has transformed treatment options for melanoma patients.
- High TIL density is associated with better outcomes in various cancers.
Takeaway
This study looks at special immune cells in melanoma that can help doctors understand how well a patient might do and how to treat them better.
Methodology
The review assesses existing literature on TILs in melanoma, focusing on their prognostic significance and therapeutic potential.
Limitations
Challenges include understanding TIL dynamics and limitations in TIL-based therapies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website